Registration statement for securities of certain foreign private issuers

Subsequent Events (Details)

v3.19.3.a.u2
Subsequent Events (Details) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended
Mar. 11, 2019
Aug. 31, 2019
Jul. 31, 2019
Apr. 29, 2019
Feb. 25, 2019
Jan. 18, 2019
May 22, 2019
Apr. 04, 2019
Dec. 31, 2018
May 31, 2018
Dec. 31, 2017
Subsequent Events (Textual)                      
Aggregate ordinary shares           4,476,192 45,000,000 9,846,156      
Warrants to purchase shares           4,476,192          
Aggregate purchase price           $ 2,350          
Total upfront payment       $ 1,000              
Wize Pharma Inc [Member]                      
Subsequent Events (Textual)                      
Aggregate ordinary shares                 356,803   356,803
ADS [Member]                      
Subsequent Events (Textual)                      
Aggregate ordinary shares                   400,000 138,890
Subsequent Events [Member]                      
Subsequent Events (Textual)                      
Aggregate ordinary shares           4,476,192          
Warrants to purchase shares           4,476,192          
Warrant exercise price $ 0.67         $ 1.30          
Aggregate purchase price           $ 2,350          
Sale of milestone description         The Company’s Distribution Agreement with CKD was amended to expand the exclusive right to distribute Namodenoson for the treatment of NASH in addition to liver cancer in South Korea. CKD has agreed to pay the Company up to an additional USD 3,000 in upfront and milestone payments payable with respect to the NASH indication.            
Total upfront payment     $ 750                
Achievement of certain milestones     $ 3,250                
Subsequent Events [Member] | Kyongbo Pharm [member]                      
Subsequent Events (Textual)                      
LongTermSpecifiedFormOfPaymentsReceived   $ 750                  
Subsequent Events [Member] | ADS [Member] | Direct Offering [Member]                      
Subsequent Events (Textual)                      
Sale of american depositary share           2,238,096          
Warrants to purchase shares           2,238,096          
Subsequent Events [Member] | NIS [Member]                      
Subsequent Events (Textual)                      
Warrant exercise price $ 2.344                    
Grant of unlisted options exercisable 400,000